Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AXIM - Axim stock rises 11% on diagnostic tests order with partner Verséa

AXIM - Axim stock rises 11% on diagnostic tests order with partner Verséa

Axim Biotechnologies Inc

  • Axim Biotechnologies ( OTCQB:AXIM ) stock rose ~11% on Oct. 4 after the company said it received an initial order of 19K point-of-care diagnostic tests and 100 readers targeting ocular surface diseases through its exclusive commercialization partner Verséa Ophthalmics.
  • The order is part of a recently announced exclusive global commercialization agreement between Verséa and Axim to support the commercial launch of sales at the 2022 American Academy of Ophthalmology (AAO) conference in Chicago, the company said in an Oct. 4 press release.
  • Axim noted that the order represented the largest revenue-generating event in the history of the company.
  • The company added that the order includes both the tear based tests for Lactoferrin and Immunoglobulin E (IgE) and associated digital reader which allows for quantitative test results.

For further details see:

Axim stock rises 11% on diagnostic tests order with partner Verséa
Stock Information
Company Name: Axim Biotechnologies Inc
Stock Symbol: AXIM
Market: OTC
Website: aximbiotech.com
Menu
AXIM AXIM Quote AXIM Short AXIM News AXIM Articles AXIM Message Board
Get AXIM Alerts

News, Short Squeeze, Breakout and More Instantly...